The goals of treatment are to decrease the frequency of angina, increase longevity, and improve patients' QOL. Management of risk factors is an essential component of this therapy. Also important is ...

In January 2006, the U.S. Food and Drug Administration (FDA) approved a new antianginal agent for the treatment of chronic stable angina, ranolazine (Ranexa™; CV Therapeutics, Inc.). The drug, ...

Stable angina can be treated with rest or nitrate medications; however, unstable angina is a medical emergency as it can lead to a heart attack. — 123rf Angina pectoris, often shortened to angina, is ...

BECAUSE angina pectoris is a consequence of inadequate myocardial oxygenation, ideal therapy for this incapacitating symptom would be directed toward both increasing coronary blood flow and decreasing ...

IN our inquiries into any particular subject of Medicine, our labours will generally be shortened and directed to their proper objects, by a knowledge of preceding discoveries. When Dr. Heberden, in ...

Angina is chest pain that happens when there isn't enough blood going to part of your heart. It can feel like a heart attack, with pressure or squeezing in your chest. It's sometimes called angina ...

Individuals with undetected stable angina pectoris (SAP) as a consequence of undiagnosed coronary artery disease are at high risk of poor quality of life and a premature fatal event (for example, ...

Angina, a type of chest pain, can be stable or unstable. Stable angina follows a predictable pattern. For example, it may occur regularly after strenuous exercise and go away shortly. Angina is a type ...

Angina occurs when part of the heart does not receive enough oxygen. It may feel like pain, squeezing, or pressure in the chest. Angina is not a disease but a symptom of another underlying condition.

This was an investigator-initiated, prospective, open-label, randomized, controlled study conducted at Hiroshima University Hospital between April 2011 and March 2013. We studied 30 patients with ...

The global angina pectoris drugs market is poised for substantial growth over the next decade, driven by a combination of rising cardiovascular disease incidence, advances in drug delivery ...